WallStreetZenWallStreetZen

NASDAQ: ONC
Beone Medicines Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Beone Medicines earnings were $68.6M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest ONC earnings report on Sep 30, 2025 announced Q3 2025 earnings of $124.8M, up 32.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ONC reported annual earnings of -$644.8M, with -26.9% growth. The next ONC earnings date is Apr 1, 2026.

ONC earnings history

Current Revenue
$5.0B
Current Earnings
$68.6M
Current Profit Margin
1.4%

ONC Return on Equity

Current Company
1.9%
Current Industry
-21.2%
Current Market
35.1%
ONC's Return on Equity (1.9%)... subscribe to Premium to read more.
High Return on Equity Performance

ONC Return on Assets

Current Company
1.1%
Current Industry
-8.8%
ONC is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ONC announces earnings.

ONC Return on Capital Employed

Current Company
3.08%
Current Industry
-3.5%
ONC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ONC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ONC$318.03M$68.55MN/A$0.05
ALNY$631.44M$313.75MN/A$2.39
INSM-$1.08B-$1.18BN/A-$6.17
ARGX$811.30M$1.51BN/A$25.02
RPRX$1.08B$770.95M+6.28%$1.79
View Top Biotech Stocks

ONC earnings dates

Next earnings date
Apr 1, 2026

Beone Medicines Earnings Reports & History FAQ

What were Beone Medicines's earnings last quarter?

On ONC's earnings call on Invalid Date, Beone Medicines (NASDAQ: ONC) reported Q3 2025 earnings per share (EPS) of $0.09, up 200% year over year. Total ONC earnings for the quarter were $124.84 million. In the same quarter last year, Beone Medicines's earnings per share (EPS) was -$0.09.

If you're new to stock investing, here's how to buy Beone Medicines stock.

When does Beone Medicines report earnings?

The next ONC earnings call is Invalid Date. Add ONC to your watchlist to be reminded of Beone Medicines's next earnings date.

Is Beone Medicines profitable or losing money?

As of the last Beone Medicines earnings report, Beone Medicines is currently profitable. Beone Medicines's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $68.55 million, a 107.97% decrease year over year.

What was ONC's earnings growth in the past year?

As of Beone Medicines's earnings date in Invalid Date, Beone Medicines's earnings has grown year over year. ONC earnings in the past year totalled $68.55 million.

What are Beone Medicines's earnings expectations?

The current EPS estimate for Beone Medicines's earnings report in Invalid Date is $1.41.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.